Our Products

Product details Products Home
Omniflox

Omniflox

Sparfloxacin

Sparfloxacin is a synthetic, broad-spectrum antibacterial agent from the difluoroquinolone family. It has been reported to be more active in vitro than ciprofloxacin against some organisms, including staphylococci and Mycobacteria, and has a much longer plasma half-life (16 hours).

Product Details

Presentation

Omniflox Tablet: Each film coated Omniflox tablet contains Sparfloxacin INN 200 mg.

Pharmacology

Sparfloxacin is a synthetic, broad-spectrum antibacterial agent from the difluoroquinolone family. It has been reported to be more active in vitro than ciprofloxacin against some organisms, including staphylococci and Mycobacteria, and has a much longer plasma half-life (16 hours).

Indication

Omniflox is indicated for the treatment of following infections due to susceptible micro-organisms:
Upper & lower respiratory tract infections including sinusitis, acute exacerbation of chronic bronchitis, community acquired and hospital acquired pneumonia.
Urinary tract infections including gonococcal and non-gonococcal urethritis, chancroid and other sexually transmitted diseases.
Skin and soft tissue infections.
Prophylactic use in different urological and ophthalmic operations.

Dosage & Administration

The recommended daily adult dose is two tablets (400 mg) on 1st day as a loading dose, followed by one tablet (200 mg) daily as a maintenance dose. Duration of maintenance treatment is 5 to 10 days. It can be taken with or without food.

Contraindications

Hypersensitivity to fluoroquinolones including sparfloxacin; growing children.

Warning & Precautions

Renal disease, gastric ulcers, concomitant use of NSAID's, avoid exposure UV radiation during treatment. In renal failure of third degree severity (creatinine clearance <30 ml/min) dosage modification is recommended 400 mg on 1st day, 200 mg on 2nd & 3rd day followed by 200 mg every 48 hours.

Side effects

Side effects are mild, transient and seldom. These are allergic reactions; photosensitization; GIT (gastro-intestinal tract) disorders including nausea, vomiting, diarrhea, headache & sleep disturbance at the start of treatment.

Drug interaction

Quinidine; sotalol; erythromycin; astemizole; terfendine; vinca alkaloids. Salts, oxides & hydroxides of Mg, Al & Ca decrease the absorption of sparfloxacin.

Use in special groups

Use in children: Below 12 years of children not recommended.
Use in pregnancy & lactation: Omniflox should be administered in pregnant women & lactating mother only if the potential maternal benefits justify the risks to the foetus/neonate.

Packing

Omniflox Tablet: Each box contains 10's tablets in Alu-Alu blister pack.

Other Products from
Antibiotic
 
Erythromycin
Erythromycin
Cefixime
Ciprofloxacin
Amoxycillin Trihydrate
Chloramphenicol
Meropenem
Cefuroxime
Cefuroxime + Clavulanic Acid
Ceftriaxone
Azithromycin
Azithromycin
Besifloxacin Hydrochloride
Ceftazidime
Clindamycin
Cefradine
Cefepime
Rifaximin
Lomefloxacin
Lemefloxacin
Amikacin Sulfate
Sparfloxacin
Moxifloxacin
Moxifloxacin
Moxifloxacin (enriched with Xanthan Gum)
Gentamicin
Levofloxacin
Flucloxacillin
Tobramycin
Gatifloxacin
Cefpodoxime
Ofloxacin

© 2017. Aristopharma Ltd. All rights reserved.
Site by DIGITA iNTERACTIVE

HOME | PRODUCTS | FACILITIES | GLOBAL PRESENCE | NEWS | ABOUT US | CONTACT | CAREER

Webmail
Bookmark and Share